Esperion Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.

About ESPR

Esperion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. 

CEO
Sheldon L. Koenig
CEOSheldon L. Koenig
Employees
294
Employees294
Headquarters
Ann Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded
1998
Founded1998
Employees
294
Employees294

ESPR Key Statistics

Market cap
805.76M
Market cap805.76M
Price-Earnings ratio
-30.24
Price-Earnings ratio-30.24
Dividend yield
Dividend yield
Average volume
33.31M
Average volume33.31M
High today
$3.14
High today$3.14
Low today
$3.12
Low today$3.12
Open price
$3.13
Open price$3.13
Volume
5.92M
Volume5.92M
52 Week high
$4.18
52 Week high$4.18
52 Week low
$0.6925
52 Week low$0.6925

Stock Snapshot

The current Esperion Therapeutics(ESPR) stock price is $3.13, with a market capitalization of 805.76M. The stock trades at a price-to-earnings (P/E) ratio of -30.24.

On 2026-05-13, Esperion Therapeutics(ESPR) stock moved within a range of $3.12 to $3.14. With shares now at $3.13, the stock is trading +0.3% above its intraday low and -0.3% below the session's peak.

Trading activity shows a volume of 5.92M, compared to an average daily volume of 33.31M.

The stock's 52-week range extends from a low of $0.69 to a high of $4.18.

The stock's 52-week range extends from a low of $0.69 to a high of $4.18.

ESPR News

TipRanks 3d
Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk

Esperion Therapeutics (ESPR) has disclosed a new risk, in the Regulation category. Unlock hedge fund-level data and powerful investing tools for smarter, sharp...

Analyst ratings

86%

of 7 ratings
Buy
0%
Hold
85.7%
Sell
14.3%

People also own

Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.